Article
Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.
Pharmacogenomics - 1 Sept 2010
Graziano Francesco, Ruzzo Annamaria, Canestrari Emanuele, Catalano Vincenzo, Santini Daniele, Galluccio Nadia, Loupakis Fotios, Alessandroni Paolo, Spada Daniele, Ficarelli Rita, Bisonni Renato, D'Emidio Silvia, Vincenzi Bruno, Angeletti Silvia, Salvatore Lisa, Cremolini Chiara, Tonini Giuseppe, Falcone Alfredo, Magnani Mauro
Abstract excerpt
AIM: IGF binding protein-3 (IGFBP-3) displays growth inhibitory/proapoptotic action and counteracts the IGF-1 tumor-promoting effects by downregulating its bioavailability. We investigated whether IGFBP-3 SNPs determining high IGFBP-3 circulating levels are associated with improved survival of pa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
